Diabetes Drug Actos Caused Bladder Cancer, Alleges Lawsuit Filed by Parker Waichman LLP

Parker Waichman LLP has filed a lawsuit on behalf of a New Hampshire man who allegedly developed bladder cancer after taking Actos (pioglitazone) for several years. Allegedly, Takeda, the manufacturer of the drug, was aware that taking Actos could increase the chances of the patient developing bladder cancer but did not warn the Plaintiff or other consumers.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
The lawsuit alleges that Takeda was aware that use of Actos could cause bladder cancer, but did not adequately warn the Plaintiff, his doctor or other consumers taking the drug.

New York, New York (PRWEB) April 23, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a lawsuit on behalf of a New Hampshire man who alleges that use of the Type 2 diabetes drug Actos (pioglitazone) caused bladder cancer. The suit was filed on April 2nd in the U.S. District Court for the Western District of Louisiana (Case No. 6:13-cv-0702). There, it is pending in the Actos federal multidistrict litigation entitled In Re: Actos (Pioglitazone) Products Liability Litigation (MDL No. 6:11-md-2299). Jerrold S. Parker, founding partner of Parker Waichman LLP, serves on the Plaintiffs’ Steering Committee in the MDL. Takeda Pharmaceuticals, America; Takeda Pharmaceuticals USA, Inc. f/k/a Takeda Pharmaceuticals North America, Inc.; Takeda Pharmaceutical Company Limited; and Eli Lilly and Company have been named as Defendants.

According to the Complaint, the Plaintiff started taking Actos in April 2004. He was diagnosed with bladder cancer in August 2008, allegedly due to the use of Actos. The lawsuit alleges that Takeda was aware that use of Actos could cause bladder cancer, but did not adequately warn the Plaintiff, his doctor or other consumers taking the drug. He is suing for permanent injuries, emotional distress, economic loss due to medical expenses and living-related expenses due to a new lifestyle.

The U.S. Food and Drug Administration (FDA)* has warned that taking Actos for one year may significantly increase the risk of bladder cancer. The agency updated the medication’s safety label in 2011 to address these risks. The findings were based on an ongoing 10-year study by Kaiser Permanente.

Last May, the British Medical Journal** published a study showing that patients who took Actos for two years were twice as likely to develop bladder cancer. In July, a study published in the Canadian Medical Association Journal*** found that Actos users were 22 percent more likely to develop bladder cancer.

*http://www.fda.gov/Drugs/DrugSafety/ucm266555.htm

**http://www.bmj.com/content/344/bmj.e3645

***http://www.cmaj.ca/content/early/2012/07/03/cmaj.112102

Parker Waichman LLP continues to offer free legal consultations to victims of Actos injuries, including bladder cancer, heart problems, and eye injuries. If you or a loved one were diagnosed with bladder cancer after taking Actos, please contact their office by visiting yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).

Contact:
Parker Waichman LLP
Gary Falkowitz, Managing Attorney
(800) LAW-INFO
(800) 529-4636
http://www.yourlawyer.com


Contact

Follow us on: Contact's Facebook Contact's Twitter Contact's LinkedIn Contact's Google Plus